Study reveals: sticking to sarcoidosis meds may improve outcomes
NCT ID NCT05438095
First seen Jun 27, 2026 · Last updated Aug 14, 2026 · Updated 2 times
Summary
This study looks at how well people with sarcoidosis take their prescribed medicines and whether that affects their disease. Researchers will follow 150 adults in Maryland and D.C. for one year, tracking lung function, symptoms, and hospital visits. The goal is to find ways to help patients stick to their treatment plans.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MEDICATION ADHERENCE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Johns Hopkins Bayview Asthma and Allergy Center
Baltimore, Maryland, 21224, United States
-
Johns Hopkins Greenspring Station
Timonium, Maryland, 21093, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Heart scans may unlock hidden risks in minority communities
- Can a smartphone app help people stick to their meds?
- A new approach to dementia care: families team up on medications
- Can immune profiling unlock the hidden stages of tuberculosis?
- Can a new infusion drug tame lung inflammation and cut steroid use?
- Smartphone messages may boost medication adherence after liver transplant